With the analysis among 79,742 patents, we discovered top 455 key players by total patent application. Immatics Biotechnologies GmbH, Novartis AG, Incyte Corp. are dominant in this area. They take 6.09% of the total patent filing.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 1,731
Basel-Stadt, Switzerland
Patent: 1,600
Delaware, United States
Patent: 1,522
F. Hoffmann-La Roche Ltd.
California, United States
Patent: 1,305
New York, United States
Patent: 1,178
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 861
New York, United States
Patent: 755
Hessen, Germany
Patent: 740
California, United States
Patent: 567
With the analysis among 5,674 patents, we discovered top 368 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, DRAGONFLY Therapeutics, Inc., Phanes Therapeutics, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 368
Phanes Therapeutics, Inc.
California, United States
Patent: 91
Utrecht, Netherlands
Patent: 74
California, United States
Patent: 67
Massachusetts, United States
Patent: 66
Herefordshire, United Kingdom
Patent: 66
Massachusetts, United States
Patent: 59
California, United States
Patent: 58
With the analysis among related 64,224 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Immatics Biotechnologies GmbH, Incyte Corp., The Board of Regents of The University of Texas System take 4.72% of patent filing during this period.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 1,043
Delaware, United States
Patent: 998
The Board of Regents of The University of Texas System
Texas, United States
Patent: 993
Basel-Stadt, Switzerland
Patent: 716
New York, United States
Patent: 690
Regents of the University of California
California, United States
Patent: 675
F. Hoffmann-La Roche Ltd.
California, United States
Patent: 521
Institut National de la Santé et de la Recherche Médicale
Memorial Sloan-Kettering Cancer Center
New York, United States
Patent: 490
With the analysis among related 64,224 patents in last 5 years, we discover 89 new entrants. DRAGONFLY Therapeutics, Inc., Lunella Biotech Inc, Revolution Medicines, Inc. are the most active new entrants in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 368
Revolution Medicines, Inc.
California, United States
Patent: 140
Suzhou Yasheng Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 132
Texas, United States
Patent: 102
Cambridgeshire, United Kingdom
Patent: 98
The Francis Crick Institute Ltd.
Phanes Therapeutics, Inc.
California, United States
Patent: 91
Ascentage Pharma Group Corp. Ltd.
Shanghai Shi, China
Patent: 80
Utrecht, Netherlands
Patent: 74
With the analysis among 22,359 patents, we discovered top 259 universities and scientific research institutions by total patent application. The Johns Hopkins University, President & Fellows of Harvard College, Massachusetts Institute of Technology are dominant in this area. They take 13.87% of the total patent filing.
The Johns Hopkins University
President & Fellows of Harvard College
Massachusetts, United States
Patent: 213
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 193
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 191
Connecticut, United States
Patent: 183
New York, United States
Patent: 177
North Carolina, United States
Patent: 174
Georgia, United States
Patent: 163
University of Southern California
California, United States
Patent: 147
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 130